Cover Image
市場調查報告書

Thermalin Diabetes, LLC :產品平台分析

Thermalin Diabetes, LLC - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 314193
出版日期 內容資訊 英文 26 Pages
訂單完成後即時交付
價格
Back to Top
Thermalin Diabetes, LLC :產品平台分析 Thermalin Diabetes, LLC - Product Pipeline Review - 2015
出版日期: 2015年04月30日 內容資訊: 英文 26 Pages
簡介

Thermalin Diabetes, LLC 是以製造胰島素類似物為主的生物科技企業。該公司的治療性蛋白質常用於治療糖尿病及相關併發症上。

本報告提供Thermalin Diabetes, LLC 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Thermalin Diabetes, LLC的基本資料

  • Thermalin Diabetes, LLC概要
  • 主要資訊
  • 企業資料

Thermalin Diabetes, LLC :R&D概要

  • 主要的治療範圍

Thermalin Diabetes, LLC :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Thermalin Diabetes, LLC :開發中產品概況

  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Thermalin Diabetes, LLC :藥物簡介

  • T-0005
  • Ultra Stable Biphasic Insulin Analogs for Diabetes
  • CHLOROLOG
  • Insulin Analogs 1
  • Insulin Analogs 2
  • Tissue-Selective Insulin Analogs for Diabetes
  • Ultra-Rapid-Acting Insulin Analogs for Diabetes

Thermalin Diabetes, LLC :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Thermalin Diabetes, LLC :暫停中的計劃

Thermalin Diabetes, LLC :總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07012CDB

Summary

Global Markets Direct's, 'Thermalin Diabetes, LLC - Product Pipeline Review - 2015', provides an overview of the Thermalin Diabetes, LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Thermalin Diabetes, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Thermalin Diabetes, LLC including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Thermalin Diabetes, LLC's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Thermalin Diabetes, LLC's pipeline products

Reasons to buy

  • Evaluate Thermalin Diabetes, LLC's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Thermalin Diabetes, LLC in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Thermalin Diabetes, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Thermalin Diabetes, LLC and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Thermalin Diabetes, LLC
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Thermalin Diabetes, LLC and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Thermalin Diabetes, LLC Snapshot
    • Thermalin Diabetes, LLC Overview
    • Key Information
    • Key Facts
  • Thermalin Diabetes, LLC - Research and Development Overview
    • Key Therapeutic Areas
  • Thermalin Diabetes, LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Thermalin Diabetes, LLC - Pipeline Products Glance
    • Thermalin Diabetes, LLC - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Thermalin Diabetes, LLC - Drug Profiles
    • T-0005
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CHLOROLOG
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Insulin Analogs 1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Insulin Analogs 2
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Recombinant Peptides to Agonize Insulin Receptor for Diabetes
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Tissue-Selective Insulin Analogs for Diabetes
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Ultra-Rapid-Acting Insulin Analogs for Diabetes
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Thermalin Diabetes, LLC - Pipeline Analysis
  • Thermalin Diabetes, LLC - Pipeline Products by Target
  • Thermalin Diabetes, LLC - Pipeline Products by Route of Administration
  • Thermalin Diabetes, LLC - Pipeline Products by Molecule Type
  • Thermalin Diabetes, LLC - Pipeline Products by Mechanism of Action
  • Thermalin Diabetes, LLC - Dormant Projects
  • Thermalin Diabetes, LLC - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Thermalin Diabetes, LLC, Key Information
  • Thermalin Diabetes, LLC, Key Facts
  • Thermalin Diabetes, LLC - Pipeline by Indication, 2015
  • Thermalin Diabetes, LLC - Pipeline by Stage of Development, 2015
  • Thermalin Diabetes, LLC - Monotherapy Products in Pipeline, 2015
  • Thermalin Diabetes, LLC - Preclinical, 2015
  • Thermalin Diabetes, LLC - Discovery, 2015
  • Thermalin Diabetes, LLC - Pipeline by Target, 2015
  • Thermalin Diabetes, LLC - Pipeline by Route of Administration, 2015
  • Thermalin Diabetes, LLC - Pipeline by Molecule Type, 2015
  • Thermalin Diabetes, LLC - Pipeline Products by Mechanism of Action, 2015
  • Thermalin Diabetes, LLC - Dormant Developmental Projects,2015

List of Figures

  • Thermalin Diabetes, LLC - Pipeline by Top 10 Indication, 2015
  • Thermalin Diabetes, LLC - Pipeline by Stage of Development, 2015
  • Thermalin Diabetes, LLC - Monotherapy Products in Pipeline, 2015
  • Thermalin Diabetes, LLC - Pipeline by Top 10 Target, 2015
  • Thermalin Diabetes, LLC - Pipeline by Top 10 Molecule Type, 2015
  • Thermalin Diabetes, LLC - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top